Research ArticleArticle
Open Access
Differences in Sustained Cellular Effects of MET inhibitors Are Driven by Prolonged Target Engagement and Lysosomal Retention
Nina Berges, Jan Henrik Klug, Anna Eicher, Jennifer Loehr, Daniel Schwarz, Joerg Bomke, Birgitta Leuthner, Dominique Perrin and Oliver Schadt
Molecular Pharmacology February 2023, 103 (2) 77-88; DOI: https://doi.org/10.1124/molpharm.122.000590
Nina Berges
The Healthcare Business of Merck KGaA, Darmstadt, Germany
Jan Henrik Klug
The Healthcare Business of Merck KGaA, Darmstadt, Germany
Anna Eicher
The Healthcare Business of Merck KGaA, Darmstadt, Germany
Jennifer Loehr
The Healthcare Business of Merck KGaA, Darmstadt, Germany
Daniel Schwarz
The Healthcare Business of Merck KGaA, Darmstadt, Germany
Joerg Bomke
The Healthcare Business of Merck KGaA, Darmstadt, Germany
Birgitta Leuthner
The Healthcare Business of Merck KGaA, Darmstadt, Germany
Dominique Perrin
The Healthcare Business of Merck KGaA, Darmstadt, Germany
Oliver Schadt
The Healthcare Business of Merck KGaA, Darmstadt, Germany

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
MET Inhibitors—Mechanisms of Prolonged Target Engagement
Nina Berges, Jan Henrik Klug, Anna Eicher, Jennifer Loehr, Daniel Schwarz, Joerg Bomke, Birgitta Leuthner, Dominique Perrin and Oliver Schadt
Molecular Pharmacology February 1, 2023, 103 (2) 77-88; DOI: https://doi.org/10.1124/molpharm.122.000590
Research ArticleArticle
MET Inhibitors—Mechanisms of Prolonged Target Engagement
Nina Berges, Jan Henrik Klug, Anna Eicher, Jennifer Loehr, Daniel Schwarz, Joerg Bomke, Birgitta Leuthner, Dominique Perrin and Oliver Schadt
Molecular Pharmacology February 1, 2023, 103 (2) 77-88; DOI: https://doi.org/10.1124/molpharm.122.000590
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement